T. Rowe Price Investment Management, Inc.

Position in HAE — Haemonetics Corp

CIK 1897612 BALTIMORE, MD

Position in HAE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$82,602,825

+$48,947,170 QoQ

Shares Held

1,101,371

+84.4% QoQ

Ownership

2.42%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#13

of 327 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

T. Rowe Price Investment Management, Inc. holds $654,461,135 across 13 Medical Devices names. HAE ranks #3 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PODD	Insulet Corp	1,512,160	$230,226,360
2	NEOG	Neogen Corp	9,333,261	$83,906,016
3	HAE	Haemonetics Corp This page	1,101,371	$82,602,825
4	PRCT	PROCEPT BioRobotics Corp	3,265,704	$73,739,596
5	ALMR	Alamar Biosciences, Inc.	2,202,597	$59,668,352
6	QDEL	QuidelOrtho Corp	1,743,563	$30,547,223
7	IRMD	Iradimed Corp	318,680	$30,453,060
8	STE	STERIS plc	118,752	$25,005,608

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$82,602,825	1,101,371	+84.4%	Shares	Sole	2026-08-14
2026-03-31	$33,655,655	597,155	-29.6%	Shares	Sole	2026-05-15
2025-12-31	$68,010,080	848,535	-16.1%	Shares	Sole	2026-02-17
2025-09-30	$49,274,044	1,010,957	-36.6%	Shares	Sole	2025-11-14
2025-06-30	$118,993,026	1,594,867	-27.4%	Shares	Sole	2025-08-14
2025-03-31	$139,528,409	2,195,569	-14.0%	Shares	Sole	2025-05-14
2024-12-31	$199,401,797	2,553,814	-10.4%	Shares	Sole	2025-02-14
2024-09-30	$229,134,202	2,850,637	+73.5%	Shares	Sole	2024-11-14
2024-06-30	$135,920,508	1,642,941	+34.9%	Shares	Sole	2024-08-14
2024-03-31	$103,974,308	1,218,211	+11.5%	Shares	Sole	2024-05-15
2023-12-31	$93,402,487	1,092,299	+29.0%	Shares	Sole	2024-02-14
2023-09-30	$75,866,824	846,917	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.